GURUFOCUS.COM » STOCK LIST » Technology » Software » Deversify Health AB (OSTO:DEV) » Definitions » Notes Receivable

Deversify Health AB (OSTO:DEV) Notes Receivable : kr0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Deversify Health AB Notes Receivable?

Deversify Health AB's Notes Receivable for the quarter that ended in Jun. 2024 was kr0.00 Mil.


Deversify Health AB Notes Receivable Historical Data

The historical data trend for Deversify Health AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deversify Health AB Notes Receivable Chart

Deversify Health AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - - -

Deversify Health AB Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Deversify Health AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Deversify Health AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of Deversify Health AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Deversify Health AB Business Description

Traded in Other Exchanges
N/A
Address
Ulls vag 29C, Uppsala, SWE, 756 51
Deversify Health AB offers health tech solutions for consumers. The company develops and commercializes mobile electronic devices and apps to monitor biomarkers for individualized health, specializing in breathalyzers. The company also develops and provides education services regarding metabolic health and personalized nutrition.